From: WISP2 exhibits its potential antitumor activity via targeting ERK and E-cadherin pathways in esophageal cancer cells
Parameter
Cases
5-y survival rate (%)
χ2
P
WISP2
146.25
< 0.01
+
77
85.7
–
139
5.76